Medical News

RSS

Latest science from area of network biology

This week experts from around the world will meet to discuss how network models can be applied to the study and targeting of complex diseases such as cancer, diabetes and neurological disorders.

7 May 2012

Recession drives Medicaid spending

Job losses and diminishing income have pushed Medicaid spending to new heights, according to a study released Friday.

7 May 2012

CardioKinetix Parachute Ventricular Partitioning Device trial data presented at 2012 EuroPCR

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that clinical trial data from the first-of-its-kind Parachute Ventricular Partitioning Device for the treatment of patients with ischemic heart failure will be presented at the 2012 EuroPCR Conference in Paris.

7 May 2012

Emdeon expands healthcare payment integrity solutions with TC3 acquisition

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced its acquisition of TC3Health, Inc. The acquisition of TC3 expands Emdeon's already robust Payment Integrity solutions for healthcare payers to include new claims analytics tools from pre-adjudication through post-payment, as well as access to a broad out-of-network claims cost management solution.

7 May 2012

Positive results from PROLOR Biotech's hGH-CTP Phase II trial for growth hormone deficiency

PROLOR Biotech, Inc. today reported top-line results from a Phase II four-month treatment extension study of hGH-CTP, its long-acting version of human growth hormone, in growth hormone deficient adults.

7 May 2012

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data for its NDV-3 vaccine program in a second Phase 1 study.

7 May 2012

Obama, Romney and their supporters debate government role in health care

[Bill] Clinton defended the Affordable Care Act that Obama signed into law in 2010, which is now the subject of debate among U.S. Supreme Court justices who are weighing the constitutionality of the legislation's requirement that all people have health insurance.

7 May 2012

Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.

7 May 2012

Nuvo receives BfArM positive opinion for Pliaglis

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that it has received notice of a positive opinion from the European Decentralized Procedure for the approval of Pliaglis from the German Federal Institute for Drugs and Medical Devices (BfArM), the reference member state.

7 May 2012

Chesapeake Regional Medical Center rolls out automated disinfection robot

Chesapeake Regional Medical Center rolled out the newest member of its environmental team last week, a five-foot, automated disinfection robot named Tru-D (Total Room Ultraviolet Disinfection). Implementation of the mobile, high-tech disinfection device is part of a $2 million CDC grant awarded to Duke University for the prevention of healthcare-associated infections (HAI's).

7 May 2012

Keryx, Aeterna Zentaris execute perifosine license termination and technology transfer agreement

Keryx Biopharmaceuticals, Inc. today announced that the Company and Aeterna Zentaris Inc. have executed a License Termination and Technology Transfer Agreement, whereby the KRX-0401 (perifosine) license agreement has been terminated and all license rights have reverted back to Aeterna Zentaris.

7 May 2012

Data from Idera IMO-8400 preclinical studies for SLE and psoriasis presented at AAI meeting

Idera Pharmaceuticals, Inc. today announced data from preclinical studies of IMO-8400, demonstrating a novel mechanism of action that may be applicable to the treatment of systemic lupus erythematosus (SLE) and psoriasis. IMO-8400 is an inhibitor of specific Toll-like receptors (TLRs).

7 May 2012

New communication technologies in healthcare pre-collection services

Mnet Financial, Inc., the premier solution for providing patient Pre-Collections, Collections and Payment Services for Ambulatory Surgical Centers and Hospitals throughout the United States, announced a focus on the use of new communication technologies in Pre-Collection Services.

7 May 2012

Unigene first quarter net loss decreases to $6.0 million

Unigene Laboratories, Inc., today announced financial results for the first quarter ended March 31, 2012.

7 May 2012

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).

7 May 2012

AssureRx introduces new pharmacogenomic test for ADHD

AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.

7 May 2012

First Edition: May 7, 2012

Today's health policy highlights include reports detailing what's ahead this week on Capitol Hill as well as state-level developments.

7 May 2012

Walgreens acquires certain assets of BioScrip

Walgreen Co. today announced that it has completed its acquisition of certain assets of BioScrip, Inc.'s community specialty pharmacies and centralized specialty and mail service pharmacy businesses.

7 May 2012

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application

Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.

7 May 2012

ADVENTRX first quarter net loss increases to $4.2M

ADVENTRX Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012.

7 May 2012

Medical News

Latest science from area of network biology

Recession drives Medicaid spending

CardioKinetix Parachute Ventricular Partitioning Device trial data presented at 2012 EuroPCR

Emdeon expands healthcare payment integrity solutions with TC3 acquisition

Positive results from PROLOR Biotech's hGH-CTP Phase II trial for growth hormone deficiency

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

Obama, Romney and their supporters debate government role in health care

Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

Nuvo receives BfArM positive opinion for Pliaglis

Chesapeake Regional Medical Center rolls out automated disinfection robot

Keryx, Aeterna Zentaris execute perifosine license termination and technology transfer agreement

Data from Idera IMO-8400 preclinical studies for SLE and psoriasis presented at AAI meeting

New communication technologies in healthcare pre-collection services

Unigene first quarter net loss decreases to $6.0 million

Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression

AssureRx introduces new pharmacogenomic test for ADHD

First Edition: May 7, 2012

Walgreens acquires certain assets of BioScrip

Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application

ADVENTRX first quarter net loss increases to $4.2M

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News